Strategic PR Plan PPT

•

20 likes•18,801 views

Presentation form for class project. Group created a strategic plan for Gardasil for Males HPV Vaccine. Details can be found in the word document titled Strategic PR Plan.

Gardasil for Males Presented by: Jim Nowierski, Tiffany Sarpy, Lin Sun & Yue Zheng

About Merck Founded in 1891 106,000 Employees Operates in 140 Countries $47 Billion in Revenues Products Prescription Medications OTC Goods Animal Health Products Vaccines

About Merck June 8, 2006 – FDA approves Gardasil. Females between 9 and 26 years-old. HPV types: 6 11 16 18

About HPV Most common STD in the United States. Infects 62 million Americans each year. Most do not know they are infected.

About HPV Females Cervical Cancer Anal Cancer Neck Cancer Genital Warts Males Penile Cancer Anal Cancer Neck Cancer Genital Warts

Females vs. Males Females 9,710 new cases of cervical cancer annually 3,700 annual deaths Males 304,000 contract genital warts each year

Business Goal As a publically traded company…

Opportunity Global sales of Gardasil 2006 $234.8 million 2007 $1.48 billion 2008 $1.4 billion Why the decline? Strong launch uptake Vaccination for children program

Opportunity Expanding the application of Gardasil Women 27 to 45 Failed New Markets???

The Real Opportunity October 16, 2009 - the FDA approved Gardasil. males between 9 and 26 years-old. HPV types: 6 11

The Real Opportunity Increase revenues by $200 to $300 million. Patent expires in 2026.

Research Goals Identify audiences Identify influencers Identify perceptions Gather trial research Gather information at specified checkpoints Determine the best communicational methods

Research Methods Primary Qualitative Focus Groups Field Reports Quantitative Surveys Secondary Media tracking Gathering information Monitoring

SWOTS Opportunities FDA & NCI Support Potential Market Expansion Threats HPV clears up Only genital warts Price variations Decrease in female vaccinations

Communication Goals Increase awareness Effects Application

Objectives 6 months 7% change in the perception 7% increase in awareness 1 year 15% change in perception 15% increase in awareness 10% increase in medical offices

Key Audiences Parents Males 13-17 18-26 Heterosexual Homosexual Females 18-26 General Practitioners & Obstetricians/Gynecologists Media & Influences

Key Messages Gardasil will protect you and your partner HPV can only be avoided through prevention HPV causes more than cervical cancer

Strategies Grassroots campaign in test market Emphasize importance Aggressive & proactive tone Build partnerships Media relations Target Medical professionals Key locations Ensure easy access to info.

Tactics Location College tour Drug Reps. Partnerships Sex Ed. Materials Website Advertising Women’s magazines Men’s magazines Hetero- & Homosexual PSAs Pharmacies & Clinics Media Tour

Evaluation Pre-launch Determine: Perception Awareness Determine how many offer/carry vaccine. Post-launch 6 months Assess changes: Perception Awareness 1 years Repeat Determine how many offer/carry vaccine.

Timeline http://www.tomsplanner.com/shared/merck/

Similar to Strategic PR Plan PPT

Lim 10 stepmarketingplan gardasil

dan883

This document outlines a 10 step marketing plan for Gardasil, a HPV vaccine. The primary target market is females ages 9 to 26. Competitors include other HPV vaccine brands and prevention methods. The plan's first 5 steps define the target market, needs/expectations, competition, identify Gardasil's unique positioning preventing 70% of cervical cancers and 90% of genital warts, and estimate market size. The next 5 steps cover Gardasil's price, promotional strategies including various forms of advertising, global distribution through healthcare providers, and a winning strategy of product differentiation through its quadrivalent formulation and broader protection.

Hpv powerpoint bio in the news

kgreine

The document discusses the human papillomavirus (HPV) vaccine. It notes that HPV is the most common sexually transmitted infection and a main cause of cervical cancer. The vaccine is effective for females ages 9 to 26 and is recommended for all girls ages 11-12. While the vaccine effectively prevents pre-cancerous changes, only one-third of girls receive all three doses. The document addresses common myths about the vaccine's safety and effectiveness and cites credible sources like the CDC to dispel these myths. It concludes that accelerating HPV vaccination rates remains an important public health goal.

More than one-third of parents are not aware of CDC recommendations to vaccin...

South Nassau Communities Hospital

Risk Communication and Medical Decision Making

Informed Medical Decisions Foundation

1. Collective statistical illiteracy in healthcare is widespread among physicians, patients, and politicians due to non-transparent framing of information and lack of risk communication training. 2. Studies show physicians and the public poorly understand concepts like survival rates, risk reductions, and probabilities related to cancer screenings. 3. Implementing transparent risk communication frameworks in medical education and public health materials is needed to improve informed decision making.

Gsk 10stepmarketingplantashatan

Tasha Tan

1) GSK's target market for Cervarix is women worldwide, especially classes A, B, and C in the Philippines who have active lifestyles and value health. 2) Cervarix competes with Merck's Gardasil vaccine and traditional medicines to prevent HPV infection and cervical cancer. 3) GSK should differentiate Cervarix more from Gardasil through evidence-based marketing that highlights Cervarix's benefits to capture the estimated PHP 7.78 billion market in the Philippines.

Non invasive prenatal testing (nipt) market

Akshay Shinde

Asia Cervical Cancer Screening Market

Renub Research

What Black Women Need to Know About Cervical Cancer

bkling

Attitudes, knowledge, and practices in relation to cervical

Tariq Mohammed

This document summarizes a study that assessed knowledge, attitudes, and practices related to cervical cancer screening among women in Saudi Arabia. 500 women completed questionnaires. The study found: 1) 67.6% of women were aware of Pap smear screening but only 16.8% had ever had the test, with the main reason being lack of awareness. 2) Knowledge of HPV as a cause of cervical cancer was reported by 14.4% of women and awareness of the HPV vaccine was 9.8%. 3) After receiving an educational pamphlet, 58.4% of women expressed willingness to get screened and 76.2% supported introducing the HPV vaccine, indicating awareness needs to be improved.

Us breast cancer therapy market opportunity analysis

KuicK Research

NVTA Overview for Investors April 2016

invitaeir

Invitae is a genetic testing company that aims to bring genetic information into mainstream medical practice by making genetic testing affordable and accessible. The document discusses Invitae's mission, growth in 2015, and goals for 2016. Key points include: - Invitae doubled its genetic test menu in 2015 to over 600 genes and aims to have over 1,000 genes by the end of 2016. - Volume grew significantly in 2015 from 229 tests in Q1 to over 7,000 tests in Q4 as prices decreased and content expanded. - Reimbursement contracts increased to include major insurers which will help drive further volume growth. - The goal for 2016 is to continue expanding content, driving

Disease awareness campaign awareness pm360 3

DarrenKong4

This presentation deck was used in the October 2019 PM360 webinar sponsored by QxMD. Description: Generating top-of-mind awareness is a key challenge in diagnosing both rare and non-rare diseases that otherwise could be missed. Creating that awareness is one of the biggest challenges for pharmaceutical marketers. Join this webcast to explore the modern disease state awareness campaign and how innovative platforms can help you bring your information closer to the point of care, all from the perspective of a practicing clinician.

D T C Advertising

guest78c907

The document discusses direct-to-consumer (DTC) advertising of prescription drugs in the United States. It provides background on the history of DTC advertising and FDA regulation. Both supporters and critics of DTC advertising are discussed. Supporters argue that it educates patients, prompts discussions with doctors, and empowers consumers, while critics argue that it can mislead patients and inappropriately influence them to request drugs. Spending on DTC advertising by the pharmaceutical industry has risen dramatically in recent decades.

MHC 750 JH 01 Direct To Consumer Drug Advertising

Leslie Pirtle, MM, MEd

Direct To Consumer Drug Advertising

guest78c907

CERVICAL CANCER AWARENESS MONTH

23mdg-moodyafb

Cervical Cancer Awareness Month is observed in January to educate women about the importance of Pap tests for early detection of cervical cancer. Approximately 11,000 American women will be diagnosed with cervical cancer this year, and nearly 4,000 will die from advanced disease if undetected. Pap tests are crucial for finding pre-cancerous cells early yet many women do not get screened regularly. The HPV vaccine Gardasil protects against cancer-causing HPV types and is available to males and females ages 9 to 26, but does not replace the need for continued Pap tests according to current guidelines.

Take a look at the below link and then answer the below questions .docx

ssuserf9c51d

Take a look at the below link and then answer the below questions from each of their points of view: Link: https://www.ted.com/talks/john_wilbanks_let_s_pool_our_medical_data/transcript?language=en When you're getting medical treatment, or taking part in medical testing, privacy is important; strict laws limit what researchers can see and know about you. But what if your medical data could be used — anonymously — by anyone seeking to test a hypothesis? John Wilbanks wonders if the desire to protect our privacy is slowing research, and if opening up medical data could lead to a wave of health care innovation. For this blog and tying all the topics covered in the class about the epistemology of knowledge, what is your opinion on this matter? Should we share or should we not share? To be or not to Be? I want you to answer this from different points of view: The Patient: The Mother/Father/Son/Daughter/Husband/Wife/Partner/Friend who is trying to help: The Doctor: The Hospital Administrator: The Researcher: The Companies/Big Pharma: The Government: The Government Watchdogs making sure rules are enforced: The Philanthropists: He slammed the papers down on the table. "Doctor, I won't do it! I just saw on the news that the prostate blood test is useless at my age. It's milking the system." His face showed determination and defiance as his wife looked on in the corner. No amount of entreating could get him to budge on the subject. Forget the 10 years of my life I had sacrificed in the pursuit of medical knowledge, he had crowdsourced on Facebook information about the prostate specific antigen test; the difference is subtle, but I had gone to medical school and he had gone to Google. Posting information on their health and all their test results is a routine event for Friday Facebook users. Proclaiming quackery, he left my office determined never to return. Patients want that aggregation of data. Appealing to their practical nature, the more data, the faster we get to a solution, and if it contributes to research and a better future, it can only be the right decision. Family and friends would likely agree, maintaining that in the best interest of the patient, posting data, even without the benefit of anonymity, is acceptable. As MIPS / MACRA move towards population management, more integrated metrics would be of great interest to the hospital administrator as well and allows for an understanding of which markets are likely to produce the best reimbursements by virtue of their higher baseline of health; not surprisingly, we know higher income demographics produce the most compliant patients with the best medical outcomes, which is why most hospitals now are closing shop in poor neighborhoods, despite their need, and opening up in upscale areas with not only an assured revenue stream of insured clients, but better access to medications for diabetes control, better access to nutrition which means faster and improved healing post-surgery, and lower l ...

UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain

Lifecare Centre

Breast Light Business Plan.pptx

WasiemHelaly

This document presents a business plan for Breast Light, a device for early breast cancer detection. Breast cancer is a major global problem, particularly in the Arab world where incidence is higher and median age of patients is 10 years younger. The plan positions Breast Light as a home alternative to mammograms that is accurate and easy to use. The marketing strategy differentiates Breast Light based on product accuracy, company experience, and process excellence. It also diversifies based on segmenting customers by age, country, and role (patients, doctors). Tactics include awareness campaigns and developing marketing tools. Strengths include product uniqueness and experience, while weaknesses are potential cost and reliance on mammograms. Opportunities exist in awareness campaigns and

Cervical Cancer

fitango

Cervical cancer develops in a woman's cervix. It is usually caused by HPV infection and can be prevented through regular Pap screening tests and HPV vaccination. Early stage cervical cancer may not have symptoms but advanced cases may cause abnormal bleeding. Diagnosis involves examination and testing to determine stage. Treatment options depend on stage but may include surgery, chemotherapy, and radiation. Regular screening is important for prevention.

Similar to Strategic PR Plan PPT (20)

Lim 10 stepmarketingplan gardasil

Hpv powerpoint bio in the news

More than one-third of parents are not aware of CDC recommendations to vaccin...

Risk Communication and Medical Decision Making

Gsk 10stepmarketingplantashatan

Non invasive prenatal testing (nipt) market

Asia Cervical Cancer Screening Market

What Black Women Need to Know About Cervical Cancer

Attitudes, knowledge, and practices in relation to cervical

Us breast cancer therapy market opportunity analysis

NVTA Overview for Investors April 2016

Disease awareness campaign awareness pm360 3

D T C Advertising

MHC 750 JH 01 Direct To Consumer Drug Advertising

Direct To Consumer Drug Advertising

CERVICAL CANCER AWARENESS MONTH

Take a look at the below link and then answer the below questions .docx

UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain

Breast Light Business Plan.pptx

Cervical Cancer

Strategic PR Plan PPT

1. Gardasil for Males Presented by: Jim Nowierski, Tiffany Sarpy, Lin Sun & Yue Zheng

2. About Merck Founded in 1891 106,000 Employees Operates in 140 Countries $47 Billion in Revenues Products Prescription Medications OTC Goods Animal Health Products Vaccines

3. About Merck June 8, 2006 – FDA approves Gardasil. Females between 9 and 26 years-old. HPV types: 6 11 16 18

4. About HPV Most common STD in the United States. Infects 62 million Americans each year. Most do not know they are infected.

5. About HPV Females Cervical Cancer Anal Cancer Neck Cancer Genital Warts Males Penile Cancer Anal Cancer Neck Cancer Genital Warts

6. Females vs. Males Females 9,710 new cases of cervical cancer annually 3,700 annual deaths Males 304,000 contract genital warts each year

7. Business Goal As a publically traded company…

8. Opportunity Global sales of Gardasil 2006 $234.8 million 2007 $1.48 billion 2008 $1.4 billion Why the decline? Strong launch uptake Vaccination for children program

9. Opportunity Expanding the application of Gardasil Women 27 to 45 Failed New Markets???

10. The Real Opportunity October 16, 2009 - the FDA approved Gardasil. males between 9 and 26 years-old. HPV types: 6 11

11. The Real Opportunity Increase revenues by $200 to $300 million. Patent expires in 2026.

12. Research Goals Identify audiences Identify influencers Identify perceptions Gather trial research Gather information at specified checkpoints Determine the best communicational methods

13. Research Methods Primary Qualitative Focus Groups Field Reports Quantitative Surveys Secondary Media tracking Gathering information Monitoring

14. SWOTS Strengths Revenues Development Strong Brand Network Only approval for men Weaknesses 3-doses over 6 months Costly Not all HPV types Adverse effects No website

15. SWOTS Opportunities FDA & NCI Support Potential Market Expansion Threats HPV clears up Only genital warts Price variations Decrease in female vaccinations

16. Communication Goals Increase awareness Effects Application

17. Objectives 6 months 7% change in the perception 7% increase in awareness 1 year 15% change in perception 15% increase in awareness 10% increase in medical offices

18. Key Audiences Parents Males 13-17 18-26 Heterosexual Homosexual Females 18-26 General Practitioners & Obstetricians/Gynecologists Media & Influences

19. Key Messages Gardasil will protect you and your partner HPV can only be avoided through prevention HPV causes more than cervical cancer

20. Strategies Grassroots campaign in test market Emphasize importance Aggressive & proactive tone Build partnerships Media relations Target Medical professionals Key locations Ensure easy access to info.

21. Tactics Location College tour Drug Reps. Partnerships Sex Ed. Materials Website Advertising Women’s magazines Men’s magazines Hetero- & Homosexual PSAs Pharmacies & Clinics Media Tour

22. Evaluation Pre-launch Determine: Perception Awareness Determine how many offer/carry vaccine. Post-launch 6 months Assess changes: Perception Awareness 1 years Repeat Determine how many offer/carry vaccine.

23. Timeline http://www.tomsplanner.com/shared/merck/

24. Budget

25. Questions & Comments

Strategic PR Plan PPT

More Related Content

Similar to Strategic PR Plan PPT

Similar to Strategic PR Plan PPT (20)

Strategic PR Plan PPT